This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Iteos Belgium Sa, Iteos Therapeutics Sa. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Florence Lambolez: Innovator in Anti-TIGIT Antibodies
Introduction
Florence Lambolez is a prominent inventor based in Gosselies, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of anti-TIGIT antibodies. With a total of 2 patents, her work is paving the way for advancements in cancer immunotherapy.
Latest Patents
Lambolez's latest patents focus on anti-TIGIT antibodies and antigen binding fragments that inhibit TIGIT-mediated signaling. These innovations include combinations comprising said antibodies or antigen binding fragments and methods for their use. Her research is crucial in the ongoing battle against cancer, as it aims to enhance the immune system's ability to fight tumor cells.
Career Highlights
Throughout her career, Florence has worked with notable companies such as Iteos Therapeutics SA and Iteos Belgium SA. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Anthony B Cooper and Christophe Queva. Their collective expertise has fostered an environment of innovation and discovery in the realm of immunotherapy.
Conclusion
Florence Lambolez is a trailblazer in the development of anti-TIGIT antibodies, with her patents representing significant advancements in cancer treatment. Her work continues to inspire future innovations in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile